The biggest names in health insurance, including Cigna, CVS Health’s Aetna, UnitedHealth Group’s … More
Category: 5. Health
-
GenAI Won’t Replace Doctors, But It Could Make Them Miserable
No matter how powerful generative AI becomes, physicians will still have jobs. But will those jobs … More
Will AI replace doctors? A year ago, most physicians would’ve confidently answered “no.”…
Continue Reading
-
The common blood test that predicts how fast Alzheimer’s hits
Insulin resistance detected by routine triglyceride-glucose (TyG) index can flag people with early Alzheimer’s who are four times more likely to present rapid cognitive decline, according to new research presented at the European Academy of…
Continue Reading
-
5 Timely Ideas To Improve Medicare Advantage
WASHINGTON, DC – MARCH 14: Dr. Mehmet Oz, arrives for his confirmation hearing with the Senate … More
Continue Reading
-
Superbugs in your shrimp: Deadly colistin-resistance genes ride on imported seafood
Resistance to colistin, a potent antibiotic, is on the rise.
- In 2016, researchers discovered that colistin resistance could be transferred laterally among microbes.
- Researchers have isolated genes that confer colistin resistance from…
Continue Reading
-
CDC Vaccine Advisors To Vote On Thimerosal In Flu Shots. Here’s What To Know About Thimerosal
ATLANTA, GA – OCTOBER 05: A podium with the logo for the Centers for Disease Control and Prevention … More
Continue Reading
-
HIV is surging in over-50s—But campaigns still target the young
Prevention and treatment campaigns are not adequately targeting the particular needs of the 50+ years age group.
Indeed, between 2000 and 2016, the number of adults aged 50 years and older living with HIV in sub-Saharan Africa doubled. At…
Continue Reading
-
Zapping aging cells: The fast, label-free test that could transform research
Researchers from Tokyo Metropolitan University have created a new way of telling “aged” human cells apart from younger ones using electric fields. While key markers have been found for these “senescent” cells, current methods require biochemical…
Continue Reading
-
FDA under fire: Data discrepancies uncovered in AstraZeneca approval trials
In a follow up investigation into the multibillion dollar drug ticagrelor, The BMJ has uncovered fresh concerns, this time in key platelet studies used in its FDA approval.
For more than a decade, ticagrelor (Brilinta in the US and Brilique in…
Continue Reading
-
Myth-busting study shows controversial seed oils reduce inflammation
New research that used blood markers to measure linoleic acid levels and their relation to cardiometabolic risk adds evidence that this omega-6 fatty acid may help to lower risks for heart disease and type 2 diabetes. The findings challenge…
Continue Reading